Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

HIGHLIGHTS

• who: | and collaborators from the (UNIVERSITY) have published the paper: Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma, in the Journal: (JOURNAL)

SUMMARY

@@

ACRONYMS

LAY DEFINITIONS

Licence: cc-by

Site reference: https://thescholarship.ecu.edu/bitstream/10342/12345/1/AmarImpactofOlderAgeinPatientsReceivingAtezolizumabandBevacizumabforHepatocellularCarcinoma.pdf

DOI reference: https://www.doi.org/10.1111/liv.15405

 

If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.